Healthtech deals decreased significantly in the pharma industry in H1 2022
Deals relating to healthtech in the pharmaceutical sector have seen a decrease of 20.7% from H1 2021 to H1 2022, an analysis of GlobalData's deals database reveals.
Deals relating to healthtech in the pharmaceutical sector have seen a decrease of 20.7% from H1 2021 to H1 2022, an analysis of GlobalData's deals database reveals.